Related references
Note: Only part of the references are listed.The Effect of Fibrates on Kidney Function and Chronic Kidney Disease Progression: A Systematic Review and Meta-Analysis of Randomised Studies
Alexandros Hadjivasilis et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Lifestyle-Related Risk Factors for the Incidence and Progression of Chronic Kidney Disease in the Healthy Young and Middle-Aged Population
Akihiro Kuma et al.
NUTRIENTS (2022)
Chronic Kidney Disease Stage G4 in a Diabetic Patient Improved by Multi-Disciplinary Treatments Based Upon Literature Search for Therapeutic Evidence
Hidekatsu Yanai et al.
CARDIOLOGY RESEARCH (2022)
Multi-Organ Protective Effects of Sodium Glucose Cotransporter 2 Inhibitors
Hidekatsu Yanai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease
Hidekatsu Yanai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Efficacy of statins on renal function in patients with chronic kidney disease: a systematic review and meta-analysis
Lin Zhao et al.
RENAL FAILURE (2021)
Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: an exploratory, randomized, multicenter, double-blind, placebo-controlled, parallel-group early phase 2 study
Tatsuo Hosoya et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2020)
Effects and Safety of Statin and Ezetimibe Combination Therapy in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Yi-Chih Lin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Association between serum uric acid levels and dyslipidemia in Chinese adults A cross-sectional study and further meta-analysis
Shenghui Chen et al.
MEDICINE (2020)
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J. L. Heerspink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
George L. Bakris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Serum indoxyl sulfate concentrations associate with progression of chronic kidney disease in children
Johannes Holle et al.
PLOS ONE (2020)
Uric acid and the cardio-renal effects of SGLT2 inhibitors
Clifford J. Bailey
DIABETES OBESITY & METABOLISM (2019)
Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis
Jonatan Barrera-Chimal et al.
KIDNEY INTERNATIONAL (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor
Tetsuya Taniguchi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Effect of angiotensin receptor blockers on blood pressure and renal function in patients with concomitant hypertension and chronic kidney disease: a systematic review and meta-analysis
Michel Burnier et al.
BLOOD PRESSURE (2019)
Selective Mineralocorticoid Receptor Cofactor Modulation as Molecular Basis for Finerenone's Antifibrotic Activity
Jana Grune et al.
HYPERTENSION (2018)
Identification of ABCG2 as an Exporter of Uremic Toxin Indoxyl Sulfate in Mice and as a Crucial Factor Influencing CKD Progression
T. Takada et al.
SCIENTIFIC REPORTS (2018)
Identification of Febuxostat as a New Strong ABCG2 Inhibitor: Potential Applications and Risks in Clinical Situations
Hiroshi Miyata et al.
Frontiers in Pharmacology (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Liraglutide and Renal Outcomes in Type 2 Diabetes
Johannes F. E. Mann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy - A review
Maria Erika G. Ramirez et al.
JOURNAL OF ADVANCED RESEARCH (2017)
Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis
Yen-Chung Lin et al.
PLOS ONE (2017)
The problem of cardio-renal diseases in patients with gout
Claudio Ferri
CURRENT MEDICAL RESEARCH AND OPINION (2017)
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
LDL-cholesterol lowering and renal outcomes
David D. Waters
CURRENT OPINION IN LIPIDOLOGY (2015)
Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis
Tahir Kanji et al.
BMC NEPHROLOGY (2015)
Definition of hyperuricemia and gouty conditions
Thomas Bardin et al.
CURRENT OPINION IN RHEUMATOLOGY (2014)
Allopurinol for the treatment of chronic kidney disease: a systematic review
Nigel Fleeman et al.
HEALTH TECHNOLOGY ASSESSMENT (2014)
Serum Uric Acid Is Associated with Incident Chronic Kidney Disease in Middle-Aged Populations: A Meta-Analysis of 15 Cohort Studies
Ping Zhu et al.
PLOS ONE (2014)
Hyperuricemia and Risk of Incident Hypertension: A Systematic Review and Meta-Analysis of Observational Studies
Ji Wang et al.
PLOS ONE (2014)
Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: a systematic review and meta-analysis based on observational cohort studies
Ling Li et al.
BMC NEPHROLOGY (2014)
Decreased extra-renal urate excretion is a common cause of hyperuricemia
Kimiyoshi Ichida et al.
NATURE COMMUNICATIONS (2012)
The genetic basis of hyperuricaemia and gout
Tony R. Merriman et al.
JOINT BONE SPINE (2011)
THE INCREASED PROTEIN LEVEL OF URAT1 WAS OBSERVED IN OBESITY/METABOLIC SYNDROME MODEL MICE
Masaru Doshi et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2011)
Hyperuricemia and Incident Hypertension: A Systematic Review and Meta-Analysis
Peter C. Grayson et al.
ARTHRITIS CARE & RESEARCH (2011)
Insulin resistance acts as an independent risk factor exacerbating high-purine diet induced renal injury and knee joint gouty lesions
Zhimin Miao et al.
INFLAMMATION RESEARCH (2009)
Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout
Owen M. Woodward et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout
N. Dalbeth et al.
RHEUMATOLOGY (2009)
Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population
Hirotaka Matsuo et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
Uric acid: bystander or culprit in hypertension and progressive renal disease?
Paolo Mene et al.
JOURNAL OF HYPERTENSION (2008)
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout
Veronique Vitart et al.
NATURE GENETICS (2008)
SLC2A9 Is a High-Capacity Urate Transporter in Humans
Mark J. Caulfield et al.
PLOS MEDICINE (2008)
The GLUT9 gene is associated with serum uric acid levels in Sardinia and chianti cohorts
Siguang Li et al.
PLOS GENETICS (2007)
Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output
F Perez-Ruiz et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2002)
Molecular identification of a renal urate-anion exchanger that regulates blood urate levels
A Enomoto et al.
NATURE (2002)
Share Paper
